European Journal of Cancer Oncology
Analysis of quality-adjusted time without symptoms or toxicity (Q-TWiST) in patients with metastatic hormone-sensitive prostate cancer from the ARASENS trial
The publisher did not provide an abstract — full text is available via the link below.